Evercore Wealth Management, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
Evercore Wealth Management, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2017$6,000
+50.0%
3000.0%0.00%
Q3 2017$4,000
-20.0%
3000.0%0.00%
Q2 2017$5,000
+66.7%
3000.0%0.00%
Q1 2017$3,000
-25.0%
3000.0%0.00%
Q4 2016$4,000
-42.9%
3000.0%0.00%
Q3 2016$7,000
+16.7%
3000.0%0.00%
Q2 2016$6,000
-83.8%
300
-78.8%
0.00%
-100.0%
Q1 2016$37,000
-74.3%
1,4150.0%0.00%
-71.4%
Q4 2015$144,000
-72.0%
1,415
-50.8%
0.01%
-72.0%
Q3 2015$514,000
-19.7%
2,8750.0%0.02%
-13.8%
Q2 2015$640,000
+28.8%
2,875
+15.5%
0.03%
+26.1%
Q1 2015$497,000
+99.6%
2,490
+43.0%
0.02%
+91.7%
Q4 2014$249,000
+29.7%
1,741
+18.4%
0.01%
+20.0%
Q3 2014$192,000
+3.8%
1,4700.0%0.01%0.0%
Q2 2014$185,000
-4.6%
1,4700.0%0.01%
-9.1%
Q1 2014$194,000
+288.0%
1,470
+241.9%
0.01%
+266.7%
Q4 2013$50,000
+900.0%
430
+795.8%
0.00%
Q3 2013$5,000
-99.5%
48
-99.6%
0.00%
-100.0%
Q2 2013$1,022,00011,8670.06%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders